The challenge of treating malignant bowel obstruction.
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D013505:Digestive System Surgical Procedures; D004359:Drug Therapy, Combination; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007415:Intestinal Obstruction / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy; D015282:Octreotide / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D005765:Gastrointestinal Agents; D015282:Octreotide